Gynecologic Oncology

>

Latest News

Dostarlimab shows significant survival benefits in endometrial cancer trial | Image Credit: © John Doe - © John Doe - stock.adobe.com.
Dostarlimab shows significant survival benefits in endometrial cancer trial

March 21st 2024

GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.

Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening | Image Credit: © Saiful52 - © Saiful52 - stock.adobe.com.
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening

February 21st 2024

Unifying radical hysterectomy classifications with the Querleu-Morrow | Image Credit: © Flamingo Images - © Flamingo Images - stock.adobe.com.
Unifying radical hysterectomy classifications with the Querleu-Morrow

February 16th 2024

Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.
Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more

January 19th 2024

Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment | Image Credit: © Minerva Studio - © Minerva Studio - stock.adobe.com.
Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment

January 15th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.